公开(公告)号：US20160251350A1

公开(公告)日：2016-09-01

申请号：US15054611

申请日：2016-02-26

Applicant: Genentech, Inc. ,  Array Biopharma Inc.

Inventor： Jeffrey Stults ,  Christopher M. Lindemann ,  Keith L. Spencer ,  Weidong Liu ,  Joseph Lubach

IPC: C07D471/04 ,  A61K45/06 ,  A61K31/437

CPC classification number: C07D471/04 ,  A61K31/437 ,  A61K45/06

Abstract: Disclosed are crystalline forms of (R)—N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)cyclopropanecarboxamide, and salts, solvates, and hydrates thereof, and pharmaceutical compositions, formulations and a process of manufacturing thereof.

Abstract translation: 公开了（R）-N-（4-（3-氨基哌啶-1-基）-5-溴-1H-吡咯并[2,3-b]吡啶-3-基）环丙烷甲酰胺和盐，溶剂化物的结晶形式 及其水合物，以及药物组合物，制剂及其制造方法。

公开(公告)号：US20180282324A1

公开(公告)日：2018-10-04

申请号：US15806650

申请日：2017-11-08

Applicant: Genentech, Inc. ,  Array Biopharma Inc.

Inventor： Jeffrey Stults ,  Christopher M. Lindemann ,  Keith L. Spencer ,  Weidong Liu ,  Joseph Lubach

IPC: C07D471/04 ,  A61K31/437 ,  A61K45/06

Abstract: Disclosed are crystalline forms of (R)—N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)cyclopropanecarboxamide, and salts, solvates, and hydrates thereof, and pharmaceutical compositions, formulations and a process of manufacturing thereof.